Clinical Trial Update: Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating intravenous immunoglobulins for toxic shock syndromes in children was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Infection
• Streptococcal Infection
• Toxic Shock Syndrome

Drugs mentioned

• intravenous immunoglobulins (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Staphylococcal Infection, Streptococcal Infection | Phase 4 | Status: WITHDRAWN